Press release
Acne Vulgaris Pipeline Insights Report 2023 (Updated)
Acne Vulgaris Pipeline
In the Acne Vulgaris Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Acne Vulgaris NDA approvals (if any), and product development activities comprising the technology, Acne Vulgaris collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
To explore more information on the latest breakthroughs in the Acne Vulgaris Pipeline treatment landscape of the report, click here @ Acne Vulgaris Pipeline Outlook- https://www.delveinsight.com/report-store/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Acne Vulgaris Pipeline Report
• DelveInsight's Acne Vulgaris Pipeline analysis depicts a robust space with 22+ active players working to develop 22+ pipeline treatment therapies.
• The leading companies working in the Acne Vulgaris market include Novan Inc., Bausch Health Americas, Inc., AOBiome LLC, Ascletis Pharmaceuticals, AnaptysBio Inc., Botanix Pharmaceuticals, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Xenon Pharmaceuticals Inc., Origimm Biotechnology, Boston Pharmaceuticals, Kintor Pharma, Dermavant Sciences, Eligo Bioscience, Cassiopea Inc., BioPharmX, Madam Therapeutics, SiSaf, and others.
• Promising Acne Vulgaris Pipeline Therapies in the various stages of development include S6G5T-3, 50 mg P005672-HCl, Tazarotene, Tazaroc Gel, Trifarotene 0.005 % Topical Cream, AKLIEF®, and others.
• On May 2023, Novan Inc. announced a study of phase 3 clinical trials for SB204 4%. This is a multi-center, open label long-term safety (LTS) study to be conducted in approximately 600 subjects with acne vulgaris.
• On August 2023, Teva Pharmaceuticals USA announced a study of phase 3 clinical trials for Trifarotene 0.005 % Topical Cream and AKLIEF®. To compare the safety and efficacy of the test (Trifarotene 0.005% cream), placebo (vehicle cream) and reference AKLIEF® (Trifarotene 0.005% cream) treatments to demonstrate clinical equivalence in subjects with acne vulgaris.
Acne Vulgaris Overview
Acne vulgaris is an inflammatory disorder of the pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by Cutibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrosterone (DHEA).
For further information, refer to the detailed Acne Vulgaris Unmet Needs, click here for Acne Vulgaris Ongoing Clinical Trial Analysis- https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Acne Vulgaris Emerging Drugs Profile
• IDP126: Bausch Health Americas Inc.
• DMT310: Dermata Therapeutics
Acne Vulgaris Pipeline Therapeutics Assessment
There are approx. 22+ key companies which are developing the therapies for Acne Vulgaris. The companies which have their Acne vulgaris drug candidates in the most advanced stage, i.e. Phase III include, Bausch Health Americas, Inc.
Request a sample and discover the recent advances in Acne Vulgaris Ongoing Clinical Trial Analysis and Medications, Click here for more details @ Acne Vulgaris Segmentation- https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Acne Vulgaris Drugs and Companies
• S6G5T-3: Sol-Gel Technologies Ltd.
• 50 mg P005672-HCl: Almirall S.A.
• Tazarotene: Stiefel, a GSK Company
• Tazaroc Gel: GlaxoSmithKline
Acne Vulgaris Therapeutics Assessment
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Some of the Companies in the Acne Vulgaris Therapeutics Market include-
Novan Inc., Bausch Health Americas, Inc., AOBiome LLC, Ascletis Pharmaceuticals, AnaptysBio Inc., Botanix Pharmaceuticals, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Xenon Pharmaceuticals Inc., Origimm Biotechnology, Boston Pharmaceuticals, Kintor Pharma, Dermavant Sciences, Eligo Bioscience, Cassiopea Inc., BioPharmX, Madam Therapeutics, SiSaf, and others.
Dive deep into rich insights for drugs for the Acne Vulgaris Pipeline, Click here @ Acne Vulgaris Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Acne Vulgaris Pipeline Report
• Coverage- Global
• Companies- Novan Inc., Bausch Health Americas, Inc., AOBiome LLC, Ascletis Pharmaceuticals, AnaptysBio Inc., Botanix Pharmaceuticals, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Xenon Pharmaceuticals Inc., Origimm Biotechnology, Boston Pharmaceuticals, Kintor Pharma, Dermavant Sciences, Eligo Bioscience, Cassiopea Inc., BioPharmX, Madam Therapeutics, SiSaf, and others.
• Therapies- S6G5T-3, 50 mg P005672-HCl, Tazarotene, Tazaroc Gel, Trifarotene 0.005 % Topical Cream, AKLIEF®, and others.
• Segmentation: Product Type, Molecule Type, Route of Administration
Got Queries? Find out the related information on Acne Vulgaris Merger and acquisitions, Licensing Activities- https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Acne vulgaris: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. IDP126: Bausch Health Americas, Inc.
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. DMT310: Dermata Therapeutics
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. ORG101: Origimm Biotechnology
14. Drug profiles in the detailed report…..
15. Inactive Products
16. Acne vulgaris Key Companies
17. Acne vulgaris Key Products
18. Acne vulgaris- Unmet Needs
19. Acne vulgaris- Market Drivers and Barriers
20. Acne vulgaris- Future Perspectives and Conclusion
21. Acne vulgaris Analyst Views
22. Acne vulgaris Key Companies
23. Appendix
Important Published Links
https://logcworld.mn.co/posts/46134506
https://marketingops.mn.co/posts/46134636
https://motorcycle-events.mn.co/posts/46134899
https://intuitive-schooling.mn.co/posts/46135011
https://plenty-of-heathens.mn.co/posts/advancements-and-market-trends-in-langerhans-cell-histiocytosis-treatment
https://shopsanity.mn.co/posts/understanding-the-langerhans-cell-histiocytosis-market-current-landscape-and-future-prospects
https://mccoterie.mn.co/posts/46135751
https://go02100.mn.co/posts/46136119
https://freesaloneducation.mn.co/posts/46136215
https://sokomtaani.mn.co/posts/46136615
https://skillcrush.mn.co/posts/46136691
https://advicehonest.mn.co/posts/46136795
https://evening-newss.mn.co/members/20271728
https://omind.mn.co/members/20271735
https://shop1606.mn.co/posts/45816438
https://council-of-light.mn.co/posts/45816468
https://chanspirations.mn.co/posts/45816726
https://hulu-com-forgot.mn.co/posts/45816832
https://bucketseems-news.mn.co/members/20271966
https://sentinels.mn.co/members/20272156
https://akademe.mn.co/posts/navigating-the-acne-vulgaris-market-trends-treatments-and-technological-advances
https://tc-2345.mn.co/posts/45818004
https://gene-keys-genealogy.mn.co/posts/45818150
https://take-your-phone.mn.co/posts/45818381
https://digitaldrip.mn.co/posts/45818561
https://network-24921.mn.co/posts/45818644
https://friends-of-zizira.mn.co/members/20272206
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653
https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.uplabs.com/dennydones9
https://www.zazzle.com/mbr/238605385879691977
https://independent.academia.edu/HavenSmith2
https://play.eslgaming.com/player/19736877/
https://creators.audiomack.com/dennydones1
https://piano.masto.host/@dennydones9
https://tech4goodwales.mn.co/posts/the-evolving-landscape-of-the-major-depressive-disorder-market
https://worldletinews.mn.co/members/20156129
https://community.greeka.com/users/dennydones9
https://www.exchangle.com/dennydones9
https://old.meneame.net/user/dennydones9
https://gsap.com/community/profile/159086-denny-dones/
https://www.pling.com/u/dennydones9/
https://shaunbook.mn.co/posts/type-1-diabetes-market-size-forecast-and-outlook-2032
https://zip-launchpad.mn.co/posts/45579349
https://dj-club-sf.mn.co/posts/45579415
https://wwwpreparatorianis.mn.co/posts/45579543
https://www.projectnoah.org/users/dennydones9
https://naijases.mn.co/posts/type-1-diabetes-market-future-trends-and-opportunities
https://indicate.mn.co/posts/45580238
https://linkasia.mn.co/posts/45580415
https://playhq.mn.co/posts/45580609
https://coco-quinn.mn.co/posts/45580757
https://aeros.mn.co/posts/45751762
https://churecipe.mn.co/posts/45751826
https://itravel.mn.co/members/20248979
https://hubvin.mn.co/posts/45752020
https://drujrake.mn.co/posts/45752126
https://together.mn.co/posts/45752522
https://bipolarjungle.mn.co/posts/45752571
https://mossfon.mn.co/posts/45752666
https://create-lifestyle.mn.co/posts/45753329
https://gelardas.mn.co/members/20249381
https://bloby.mn.co/posts/45753578
https://cic-mun.mn.co/posts/45753710
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Vulgaris Pipeline Insights Report 2023 (Updated) here
News-ID: 3306664 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Acne
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during the forecast period, 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Growing Acne Incidences Benefiting Global Anti-Acne Dermal Patch Market Developm …
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive…
Expanding Acne Rates Support Global Anti-Acne Dermal Patch Market Expansion
As per a new market research report launched by Inkwood Research, the Global Anti-Acne Dermal Patch Market is expected to reach $971.37 million by 2032, projecting a CAGR of 7.32% during 2023-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/anti-acne-dermal-patch-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of…
Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is…
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity…
